4.7 Article

A versatile chitosan nanogel capable of generating AgNPs in-situ and long-acting slow-release of Ag+ for highly efficient antibacterial

期刊

CARBOHYDRATE POLYMERS
卷 257, 期 -, 页码 -

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.carbpol.2021.117636

关键词

Long-lasting antibacterial; Ablation biofilms; Silver nanoparticles; Sulfated chitosan; Long-acting slow-release; Nanogel

资金

  1. National Natural Science Foundation of China [51503131, 51703245]
  2. Natural Science Foundation of Jiangsu Province [BK20181377, BK20170733]
  3. Zhejiang Provincial Medical and Health Science and Technology Plan [2021KY073]
  4. Priority Academic Program Development of Jiangsu Higher Education Institutions

向作者/读者索取更多资源

The development of a multifunctional antibacterial agent AgNPs@CS/SCS, capable of generating silver nanoparticles in-situ and providing long-acting slow-release of Ag+, shows excellent antibacterial and biofilm ablation activity. It also exhibits superior antibacterial activity in the treatment of implant infections and good biocompatibility.
Development of multifunctional antibacterial agent with long-lasting antibacterial activity and biofilm ablation performance is significant for the effective treatment of bacterial infections. Here, by utilizing the electrostatic interaction between sulfonated chitosan (SCS) and Ag+ and chitosan (CS), and the sodium borohydride reduction method, a versatile antibacterial agent (AgNPs@CS/SCS) capable of generating silver nanoparticles (AgNPs) in-situ and long-acting slow-release Ag+ was developed. AgNPs@CS/SCS has a good physiological stability and can long-acting slow-release of Ag+ due to the pH-dependent Ag+ release behavior of AgNPs. Noteworthy, AgNPs@CS/SCS can exert both excellent short- and long-term antibacterial and biofilm ablation activity. Importantly, it also exhibits superior antibacterial activity in the treatment of implant infections, accompanied by good biocompatibility. Together, this study suggest that AgNPs@CS/CSC is indeed a versatile antibacterial agent, and is expected to provide an effective treatment modality for implant infections in the clinic settings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据